We are looking for 2 to 17 years old to join a Crohn’s disease research study to help us discover more about treating inflammatory bowel disease. If you are looking for a potential new treatment option for inflammatory bowel disease or gastrointestinal disease (including associated symptoms such as cramps, iron deficiency, rectal pain, malnutrition and/or canker sores), consider one of our CD studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the CD studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing Crohn’s disease (CD) flare-ups? Local CD trial is testing a potential new medication to see if it may reduce fatigue, fever, abdominal pain, weight loss, and/or joint pain associated with Crohn’s disease (CD).
If you’re concerned about how Crohn’s disease (CD) affects your child’s life, find out more about the CD trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

We are looking for young people aged 2 to 17 years to join a study to help us discover more about treating ulcerative colitis (UC). If you are looking for a potential new treatment option for ulcerative colitis (UC) or moderately to severely active ulcerative colitis (including associated symptoms such as long-term diarrhea, joint pain, bloody stool, chronic fatigue and/or anemia), consider one of our GI clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the GI clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing IBD flare-ups? Local CD research is testing a potential new medication to see if it may reduce diarrhea with blood, kidney stones, bloody stool, chronic fatigue, and/or eye pain associated with IBD.
If you’re concerned about how IBD affects your child’s life, find out more about the CD research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for teen to join a Crohn’s disease medical research study to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or moderate to severe IBD (including associated symptoms such as long-term diarrhea, fever, cramps, malnutrition and/or canker sores), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your teen may be eligible to take part.

Your child may be eligible to take part in the IBD studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

Is your child currently experiencing moderate to severe UC flare-ups? Local Crohn’s disease (CD) medical research study is testing a potential new medication to see if it may reduce abdominal cramps, persistent diarrhea, constant need to poop, weight loss, and/or joint pain associated with moderate to severe UC.
If you’re concerned about how moderate to severe UC affects your child’s life, find out more about the Crohn’s disease (CD) medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

We are looking for children aged 2 to 17 years to join a medical research study to help us discover more about treating CD and UC. If you are looking for a potential new treatment option for CD and UC or ulcerative colitis (including associated symptoms such as diarrhea, fever, rectal pain, weight loss and/or anemia), consider one of our Crohn’s disease (CD) research. All eligible participants will receive no-cost study-related care and study medication. Your children aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

Is your child currently experiencing moderate to severe UC flare-ups? Local Crohn’s disease trial is testing a potential new medication to see if it may reduce urgency to defecate, fistula, cramps, malnutrition, and/or canker sores associated with moderate to severe UC.
If you’re concerned about how moderate to severe UC affects your child’s life, find out more about the Crohn’s disease trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

We are looking for 2 to 17 years of age to join a CD clinical trial to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or Inflammatory bowel disease (including associated symptoms such as abdominal cramps, persistent diarrhea, abdominal pain, weight loss and/or eye pain), consider one of our medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing moderately to severely active IBD flare-ups? Local Crohn’s disease clinical research study is testing a potential new medication to see if it may reduce joint pain, loss of appetite, cramps, malnutrition, and/or eye pain associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the Crohn’s disease clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.